Overview
ASSAY and Drug Development Technologies delivers access to the techniques and tools that enable new advances in early-stage screening, and lead to therapeutic compounds for drug discovery and development. This authoritative, rapidly peer-reviewed journal features original papers, application-oriented technology reviews, and reports in methodology and technology application.
ASSAY and Drug Development Technologies coverage includes:
- Assay design, target development, high-throughput technologies, and chemistry
- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis
- Approaches to assays configured for gene families, inherited, and infectious diseases
- Assays and strategies for adapting model organisms to drug discovery
- The use of stem cells as models of disease
- Translation of phenotypic outputs to target identification
- Exploration and mechanistic studies of the technical basis for assay and screening artifacts
ASSAY and Drug Development Technologies is under the editorial leadership of Editor-in-Chief Jim Inglese, PhD; Deputy Editor Andrew D. Napper, PhD, Nemours Center for Childhood Cancer Research (NCCCR); and other leading investigators. View the entire editorial board.
Audience: Drug discovery and developmental scientists, pharmaceutical and biotechnology researchers, disease foundation specialists, among others